Parisotto Shannon M's Form 4 filing
Charles River Laboratories International, Inc.CRL · filed Feb 20, 2024
- Accession no.
- 0001127602-24-005831
- Filed
- Feb 20, 2024
- Trade date
- Feb 15, 2024
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Checked
This filing lists 9 non-derivative transactions and 1 derivative transaction. Open-market sales total $1.42M. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Parisotto Shannon MCIK 0001952784 | Officer (CEVP, Disc & Safety Assessment) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 15, 2024 | Common Stock | SSaleDisposed | −291 | $237.20F2 | −$69,025.2 | 8,187 | Direct | |
| Feb 15, 2024 | Common Stock | SSaleDisposed | −1,290 | $239.28F3 | −$308,671.2 | 6,897 | Direct | |
| Feb 15, 2024 | Common Stock | SSaleDisposed | −1,617 | $240.12F4 | −$388,274.04 | 5,280 | Direct | |
| Feb 15, 2024 | Common Stock | SSaleDisposed | −610 | $241.28F5 | −$147,180.8 | 4,670 | Direct | |
| Feb 15, 2024 | Common Stock | SSaleDisposed | −632 | $242.43F6 | −$153,215.76 | 4,038 | Direct | |
| Feb 15, 2024 | Common Stock | SSaleDisposed | −604 | $243.96F7 | −$147,351.84 | 3,434 | Direct | |
| Feb 15, 2024 | Common Stock | SSaleDisposed | −749 | $244.61F8 | −$183,212.89 | 2,685 | Direct | |
| Feb 15, 2024 | Common Stock | SSaleDisposed | −89 | $245.34F9 | −$21,835.26 | 2,596 | Direct | |
| Feb 15, 2024 | Common Stock | MOption exerciseAcquired | +5,882 | $144.67 | +$850,948.94 | 8,478 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 15, 2024 | Common Stock | MOption exerciseDisposed | −5,882 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $236.71 to $237.56. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This sale occurred pursuant to a Rule 10b5-1 Trading Plan that was initially adopted on February 23, 2023.
Referenced by the price of 1 transaction in Table I.
- F3
This transaction was executed in multiple trades at prices ranging from $238.73 to $239.68. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This sale occurred pursuant to a Rule 10b5-1 Trading Plan that was initially adopted on February 23, 2023.
Referenced by the price of 1 transaction in Table I.
- F4
This transaction was executed in multiple trades at prices ranging from $239.76 to $240.55. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This sale occurred pursuant to a Rule 10b5-1 Trading Plan that was initially adopted on February 23, 2023.
Referenced by the price of 1 transaction in Table I.
- F5
This transaction was executed in multiple trades at prices ranging from $240.83 to $241.71. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This sale occurred pursuant to a Rule 10b5-1 Trading Plan that was initially adopted on February 23, 2023.
Referenced by the price of 1 transaction in Table I.
- F6
This transaction was executed in multiple trades at prices ranging from $241.97 to $242.67. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This sale occurred pursuant to a Rule 10b5-1 Trading Plan that was initially adopted on February 23, 2023.
Referenced by the price of 1 transaction in Table I.
- F7
This transaction was executed in multiple trades at prices ranging from $243.26 to $244.25. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This sale occurred pursuant to a Rule 10b5-1 Trading Plan that was initially adopted on February 23, 2023.
Referenced by the price of 1 transaction in Table I.
- F8
This transaction was executed in multiple trades at prices ranging from $244.27 to $45.24. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This sale occurred pursuant to a Rule 10b5-1 Trading Plan that was initially adopted on February 23, 2023.
Referenced by the price of 1 transaction in Table I.
- F9
This sale occurred pursuant to a Rule 10b5-1 Trading Plan that was initially adopted on February 23, 2023.
Referenced by the price of 1 transaction in Table I.